Connecticut Innovations (CI) has invested an additional $330K in Bioarray Therapeutics, a company developing a predictive test for cancer treatment that recently graduated from the UConn Technology Incubation Program (TIP). Bioarray's molecular test predicts whether later-stage breast cancer patients will respond to chemotherapy treatment.
Bioarray was founded in Boston in 2009 by Marcia Fournier, Ph.D., a biologist with over 10 years’ experience working in cancer research. Fournier chose to relocate her company to Connecticut to take advantage of the considerable support available to biotech startups in the state, such as UConn’s TIP, which is a unit of the Office of the Vice President for Research; UConn’s new NSF I-Corps site, Accelerate UConn; and Connecticut Innovations to name a few. Programs like these and others exist to advance technologies towards successful commercialization, which has long been a central mission of the OVPR. Congrats to another successful TIP graduate, Bioarray Therapeutics!
Please visit the Office of the Vice President for Research News page for full story.
For more information, contact: Jessica McBride at jessica.mcbride@uconn.edu